Template:Asthma guidelines/NHLBI EPR-3
Jump to navigation
Jump to search
National Health Lung and Blood Institute EPR-3 (2007, adapted)[1]
- Mild to moderate persistent asthma:
- Therapy should be monitored at 2-6 week intervals to ensure asthma control.
- It is recommended to perform periodic (1-6 month) assessments of asthma control and the need for therapy adjustments.
- Measurements of asthma control are the following: signs and symptoms of asthma, pulmonary function, quality of life, and history of exacerbations.
- A written asthma action plan is recommended for all patients and can be symptom or peak-flow based.